OPPENHEIMER ASSET MANAGEMENT INC. - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 48 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of CONMED CORP
ValueSharesWeighting
Q2 2023$184,560
+53.3%
120,000
+22.4%
0.00%
+50.0%
Q1 2023$120,393
+8.4%
98,0000.0%0.00%0.0%
Q4 2022$111,034
+5.7%
98,000
+2.1%
0.00%0.0%
Q3 2022$105,000
-13.2%
96,000
-4.0%
0.00%0.0%
Q2 2022$121,000
-34.9%
100,000
-7.4%
0.00%
-33.3%
Q1 2022$186,000
+1.6%
108,000
-1.8%
0.00%
+50.0%
Q4 2021$183,000
+0.5%
110,000
-6.8%
0.00%
-33.3%
Q3 2021$182,000
-7.6%
118,000
-3.3%
0.00%0.0%
Q2 2021$197,000
+28.8%
122,000
+24.5%
0.00%
+50.0%
Q1 2021$153,000
+12.5%
98,000
+1.0%
0.00%0.0%
Q4 2020$136,00097,0000.00%
Other shareholders
CONMED CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,840,000$3,184,0003.99%
SHENKMAN CAPITAL MANAGEMENT INC 10,031,000$11,377,0001.34%
ZAZOVE ASSOCIATES LLC 5,619,000$6,314,0000.82%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$10,042,0000.68%
SSI INVESTMENT MANAGEMENT LLC 5,466,000$6,120,0000.53%
ADVENT CAPITAL MANAGEMENT /DE/ 14,424,000$16,207,0000.36%
WOLVERINE ASSET MANAGEMENT LLC 30,049,000$33,801,0000.30%
MACKAY SHIELDS LLC 28,394,000$31,930,0000.22%
PALISADE CAPITAL MANAGEMENT, LP 5,271,000$5,903,0000.18%
Calamos Advisors LLC 22,766,000$25,610,0000.16%
View complete list of CONMED CORP shareholders